Paul Buckman

Paul Buckman has 39 years of experience in general management, sales, marketing, finance, international and operations in the medical device industry. In addition to LivaNova, Paul was President of the Cardiovascular Divisions of both Boston Scientific and St. Jude Medical where he implemented significant growth strategies in both core and emerging technologies. He was also a co-founder, Chairman, and CEO of ev3 which was eventually sold to Covidien for $2.5B. Paul has also had previous CEO roles with Conventus Orthopaedics, SentreHeart, Pathway Medical (sold to Bayer Healthcare), and Devax (sold to Biosensors Intl.), in addition to executive management roles at DVI (sold to Eli Lilly) and American Hospital Supply. Presently, Paul serves as a Director on the Boards of NeuroOne(Chairman), Miromatrix (Chairman), Ablative Solutions, ActivOrtho, Inc.(Co-Founder), and Aortica.